Background: The application (WO2011/102847A1) deals with methods useful for the treatment of Parkinson's disease (PD). Objective: It aims at producing mature and functional midbrain dopaminergic (mDA) neurons useful for the treatment of PD. Methods: mDA neurons were produced from neural progenitor cells or stem cells by activating both the Wnt-Lmx1a/Lmx1b and the SHH-FoxA2 signaling pathways. Results: The level of the proteins of these two synergic pathways is increased, as well as their biological activity. Conclusion: The invention provides a method for treating or preventing PD by increasing the level of at least one protein involved in an autoregulatory pathway, which is fundamental during mDA neurons differentiation.

Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1

Maccarrone M;
2012

Abstract

Background: The application (WO2011/102847A1) deals with methods useful for the treatment of Parkinson's disease (PD). Objective: It aims at producing mature and functional midbrain dopaminergic (mDA) neurons useful for the treatment of PD. Methods: mDA neurons were produced from neural progenitor cells or stem cells by activating both the Wnt-Lmx1a/Lmx1b and the SHH-FoxA2 signaling pathways. Results: The level of the proteins of these two synergic pathways is increased, as well as their biological activity. Conclusion: The invention provides a method for treating or preventing PD by increasing the level of at least one protein involved in an autoregulatory pathway, which is fundamental during mDA neurons differentiation.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11697/155847
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact